BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6420450)

  • 21. Heterogeneity of inhibition of cytolytic T lymphocyte clones by monoclonal anti-Lyt-2/3 antibodies: parallel effects on cytolysis, proliferation and lymphokine secretion.
    MacDonald HR; Glasebrook AL; Acuto O; Kelso A; Bron C; Cerottini JC
    Adv Exp Med Biol; 1982; 146():533-45. PubMed ID: 6980574
    [No Abstract]   [Full Text] [Related]  

  • 22. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
    Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
    J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
    Platsoucas CD; Good RA
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human interleukin 2: molecular biology, physiology and clinical possibilities.
    Mertelsmann R; Welte K
    Immunobiology; 1986 Sep; 172(3-5):400-19. PubMed ID: 3100434
    [No Abstract]   [Full Text] [Related]  

  • 25. T cell activation by monoclonal antibodies: an approach to study principles of immunoregulation.
    Meuer SC; Schraven B; Möbius U
    Transplant Proc; 1988 Apr; 20(2):269-72. PubMed ID: 2834837
    [No Abstract]   [Full Text] [Related]  

  • 26. A monoclonal antibody reactive with surface antigen specifically expressed by alloantigen-activated human T lymphocytes.
    Singal DP; Butler L; Chmielewski P; Liao SK
    Prog Clin Biol Res; 1983; 133():47-51. PubMed ID: 6226050
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphocyte activation. How T cells communicate.
    Breitmeyer JB
    Nature; 1987 Oct 29-Nov 4; 329(6142):760-1. PubMed ID: 3313049
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular interactions in human T-cell-mediated cytotoxicity to Epstein-Barr virus. I. Blocking of effector cell function by monoclonal antibody OKT3.
    Tsoukas CD; Fox RI; Carson DA; Fong S; Vaughan JH
    Cell Immunol; 1982 May; 69(1):113-21. PubMed ID: 6286147
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of functional cell surface antigens in T cell activation.
    Bierer BE; Mentzer SJ; Greenstein JL; Burakoff SJ
    Year Immunol; 1986; 2():39-59. PubMed ID: 2953146
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoclonal antibodies to CD2 and lymphocyte function-associated antigen 3 inhibit human thymic epithelial cell-dependent mature thymocyte activation.
    Denning SM; Tuck DT; Vollger LW; Springer TA; Singer KH; Haynes BF
    J Immunol; 1987 Oct; 139(8):2573-8. PubMed ID: 3116085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.
    Meuer SC; Fitzgerald KA; Hussey RE; Hodgdon JC; Schlossman SF; Reinherz EL
    J Exp Med; 1983 Feb; 157(2):705-19. PubMed ID: 6185617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.
    van Lier RA; Borst J; Vroom TM; Klein H; Van Mourik P; Zeijlemaker WP; Melief CJ
    J Immunol; 1987 Sep; 139(5):1589-96. PubMed ID: 2442250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of mouse T lymphocytes by a monoclonal antibody to a developmentally regulated surface aminopeptidase (THAM).
    Naquet P; Vivier I; Gorvel JP; Brekelmans P; Barad M; Bernard AM; Pierres M
    Immunol Rev; 1989 Oct; 111():177-93. PubMed ID: 2560764
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-linking of Lyt-2 (CD8) to the T cell antigen receptor optimally activates T lymphocytes.
    Boyce NW; Eichmann K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):133-7. PubMed ID: 2495596
    [No Abstract]   [Full Text] [Related]  

  • 36. Functionally relevant membrane proteins of human and guinea-pig T lymphocytes.
    Burger R; Schrod L; Schaefer H
    Mol Immunol; 1986 Nov; 23(11):1149-56. PubMed ID: 3102949
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunology in transition.
    Cruse JM; Lewis RE
    Year Immunol; 1986; 2():1-27. PubMed ID: 2437724
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunologic monitoring of Orthoclone OKT3-treated patients: the problem of antimonoclonal immune response.
    Bach JF; Chatenoud L
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):17-20. PubMed ID: 3105135
    [No Abstract]   [Full Text] [Related]  

  • 39. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 40. Accessory molecules in T lymphocyte activation.
    Miller JF
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):302-6. PubMed ID: 3106237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.